Hims & Hers Health Surges 6.25% in Trading Volume Ranking 18th

On May 12, 2025, Hims & Hers Health (HIMS) saw a trading volume of $331.9 million, ranking 18th in the day's stock market activity. The stock price surged by 6.25%, marking the second consecutive day of gains, with a total increase of 7.41% over the past two days.

Hims & Hers Health, Inc. has seen significant fluctuations in its stock price, with a 52-week high of $72.98 reached on February 19, 2025, and a 52-week low of $12.07. The stock's beta, a measure of its volatility relative to the market, stands at 1.85, indicating higher volatility compared to the broader market.

Analysts have provided varied opinions on the stock. BofA has raised its price target to $28 from $26 but maintains an underperform rating. Morgan Stanley has cut its price target to $40, reflecting a more cautious outlook. The consensus among analysts is to hold the stock, with a price target of $37.67, which represents a 31.77% downside from the current price.

Earnings for Hims & Hers Health are projected to grow by 79.31% in the coming year, from $0.29 to $0.52 per share. This anticipated growth is a key factor driving investor interest in the stock, despite the mixed analyst ratings. The company's focus on telehealth and direct-to-consumer healthcare services positions it well to capitalize on the growing demand for convenient and accessible healthcare solutions.